5 April 2012 in Journal of the Neurological Sciences
1 January 2024 in Doctor.Ru
PUProf. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
RKRussian Federation Krasnoyarsk Interregional Clinical Hospital Of Urgent Medical Care Named After N.S. Karpovich; Krasnoyarsk
Russian Federation Krasnoyarsk Interregional Clinical Hospital Of Urgent Medical Care Named After N.S. Karpovich; Krasnoyarsk
+1
Aim. To demonstrate the possibility of the influence of metabolic disorders on the formation of type 2 myocardial infarction in a young woman using a clinical example. Key points. Acute myocardial infarction in young women may not be diagnosed due to low alertness of doctors and patients themselves, since this pathology is rare at this age. However, over the past decade, the prevalence of myocardial infarction in young women has increased. The presented clinical case demonstrates the development of atherosclerotic coronary lesion with critical stenosis of the coronary artery in a 31-year-old woman, which required its endoprosthetics. The lesion manifested itself with a typical clinical picture of newly developed angina, but the patient herself assessed these symptoms incorrectly, which led to late hospitalization and the development of myocardial infarction. Acute myocardial infarction was briefly preceded by an unfavorable metabolic background: impaired carbohydrate metabolism, abdominal obesity, hypothyroidism. Conclusion. Despite the low incidence of ischemic heart disease in young women, it is necessary to be alert in the presence of myocardial ischemia symptoms in this group of patients, especially in the presence of metabolic disorders. The most important are carbohydrate metabolism disorders, abdominal obesity, and hypothyroidism. Abdominal obesity, accompanied by metabolic disorders, may be one of the possible potentially controllable risk factors for myocardial infarction in young women. Keywords: myocardial infarction, young women, abdominal obesity.
1 January 2024 in Doctor.Ru
PUProf. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
RKRussian Federation Krasnoyarsk Interregional Clinical Hospital Of Urgent Medical Care Named After N.S. Karpovich; Krasnoyarsk
Russian Federation Krasnoyarsk Interregional Clinical Hospital Of Urgent Medical Care Named After N.S. Karpovich; Krasnoyarsk
Aim. To study the incidence and risk factors associated with asthenia in patients with type 2 diabetes mellitus (DM2) in real-time clinical practice. Design. Cross-sectional clinical study. Materials and methods. 2373 patients were examined for symptoms of asthenia in outpatient settings; these patients were followed up by primary care physician therapeutics for chronic non-communicable diseases (CNCD). A group of DM2 patients (n = 527) was separated from this cohort. All patients were interviewed; their medical information was collected; their systems and organs were examined; and medical records were reviewed. A diagnosis of CNCD was confirmed on the basis of results and current clinical recommendations. Asthenia and its intensity were identified using the Multidimensional Fatigue Inventory 20 (MFI-20) and Fatigue Severity Scale (FSS). Results. The incidence of asthenia in DM2 patients was 38.52 % (n = 203) on MFI-20 and 26.76 % (n = 141) on FSS. The most common disorders on MFI-20 were: General Asthenia (20.11 %; n = 106), Physical Asthenia (16.13 %; n = 85) and Hypoactivity (13.09 %; n = 69). Presence of symptoms of asthenia in DM2 patients was associated with elderly age (60.0 (48.0; 68.0) vs. 53.0 (45.0; 64.0) years old in patients without asthenia; р < 0.0001) and multimorbidity: a history of acute myocardial infarction was observed in 7.88 % of patients with asthenia vs. 0.62 % of patients without asthenia (p < 0.00001), acute cerebrovascular accident — 5.91 % vs. 0.31 % (p < 0.0001), malignancies — 15.76 % vs. 1.54 % (p < 0.000001). DM2 patients with symptoms of asthenia were more often smokers vs. patients without asthenia (30.05 % and 20.68 %, respectively; p < 0.05), monitored their blood pressure regularly (65.02 % and 49.07 %; p < 0.001), took antihypertensives (45.32 % and 25.00 %; p < 0.00001) and statins regularly (34.48 % and 15.74 %; p < 0.00001). Conclusion. Asthenia is common in DM2 patients seeking outpatient medical assistance. Age-associated multimorbidity requiring longterm sophisticated treatment strategies and constant control of a number of parameters is probably one of the causes of asthenia in this patient category. Keywords: asthenia, type 2 diabetes mellitus, risk factors.